ArticleJournal of neurology2026
Longitudinal trajectories of apathy in Huntington's disease: a 6-year follow-up study.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveApathy is a common and debilitating neuropsychiatric symptom in Huntington's disease (HD), yet its long-term trajectory remains poorly characterized. This study examined changes in apathy in HD gene expansion carriers (HDGECs) over 6 years, using a multidimensional measure, and investigated associations with cognition, motor symptoms and depression.
methodsEighty-two HDGECs (premanifest and manifest) completed assessments at Time 0 and Time 1 with a mean follow-up interval of 6 years. Apathy was measured using the Lille Apathy Rating Scale (LARS) and the Problem Behaviors Assessment-short (PBA-s). Depressive symptoms were assessed with the Hamilton Depression Rating Scale, while social cognition and executive functioning were measured using the Emotion Hexagon and Symbol Digit Modalities Test. Within-person changes were examined using paired statistical tests and associations with clinical variables were evaluated using correlation analyses.
resultsTotal apathy scores increased significantly over 6 years, with small changes (LARS: 1.38 points; PBA-s: 1.11 points). Premanifest participants showed a selective decline in Action Initiation, whereas manifest participants exhibited a broader worsening of total apathy. Individual trajectories were variable, with both worsening and improvement observed. An increase in depressive symptoms was significantly correlated with changes in apathy but accounted for little variance.
conclusionApathy in HD shows a small but significant increase over 6 years, characterized by marked heterogeneity and changes in Action Initiation. The limited association with depression and cognition highlights apathy as an independent neuropsychiatric feature. These findings underscore the heterogeneous nature of apathy progression and the value of multidimensional assessment in longitudinal studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.